U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07791030) titled 'Diagnostic and Prognostic Roles of Procalcitonin and Highly Sensitive C-Reactive Protein in Early Detection of Burn Sepsis' on Aug. 24.

Brief Summary: This study aimed to evaluate the value of procalcitonin and highly sensitive c-reactive protein as biomarkers for early detection of sepsis in patients with major burns.

Study Start Date: Sept. 01, 2025

Study Type: OBSERVATIONAL

Condition: Diagnostic Role Prognostic Role Procalcitonin Highly Sensitive C-Reactive Protein Early Detection Burn Sepsis

Intervention: DIAGNOSTIC_TEST: Measurement of Procalcitonin level

Two samples was collected from each patient, one on admission or w...